FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. It is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, as well as Phase III trial for the treatment of Duchenne muscular dystrophy. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Over the last 12 months, insiders at FibroGen, Inc. have bought $121,354 and sold $16,524 worth of FibroGen, Inc. stock.
On average, over the past 5 years, insiders at FibroGen, Inc. have bought $381,993 and sold $5.29M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wettig Thane (CEO) — $95,470. Adib Deyaa (Chief Medical Officer) — $25,884.
The last purchase of 22,123 shares for transaction amount of $25,884 was made by Adib Deyaa (Chief Medical Officer) on 2024‑06‑12.
2024-06-12 | Adib Deyaa | Chief Medical Officer | 22,123 0.023% | $1.17 | $25,884 | -3.02% | ||
2024-03-07 | Wettig Thane | CEO | 50,000 0.0545% | $1.91 | $95,470 | -32.02% | ||
2023-09-01 | Sale | Henderson Jeffrey William | director | 2,000 0.002% | $1.03 | $2,060 | 0.00% | |
2023-08-04 | Sale | Henderson Jeffrey William | director | 2,000 0.002% | $1.91 | $3,820 | -41.88% | |
2023-07-11 | Sale | Henderson Jeffrey William | director | 2,000 0.0021% | $2.69 | $5,380 | -58.24% | |
2023-07-07 | Sale | Conterno Enrique A | Chief Executive Officer | 1,880 0.0021% | $2.80 | $5,264 | -57.78% | |
2023-06-23 | Sale | Wettig Thane | Chief Commercial Officer | 791 0.0009% | $16.53 | $13,075 | -92.77% | |
2023-06-14 | Sale | Chung Christine | SVP, China Operations | 6,250 0.0068% | $16.79 | $104,925 | -92.86% | |
2023-06-13 | Sale | Chung Christine | SVP, China Operations | 6,250 0.0066% | $17.60 | $110,000 | -93.28% | |
2023-06-09 | Sale | EDWARDS JEFFREY L | director | 7,889 0.0084% | $17.19 | $135,622 | -92.99% | |
2023-06-09 | Sale | Blaug Suzanne | director | 8,520 0.0091% | $17.20 | $146,571 | -92.99% | |
2023-06-09 | Sale | Cravatt Benjamin | director | 3,944 0.0042% | $17.17 | $67,717 | -92.99% | |
2023-06-09 | Sale | Brennan Aoife | director | 4,733 0.0051% | $17.19 | $81,367 | -92.99% | |
2023-06-08 | Sale | Henderson Jeffrey William | director | 7,000 0.0073% | $17.45 | $122,185 | -93.28% | |
2023-06-08 | Sale | Ho Maykin | director | 8,520 0.0088% | $17.44 | $148,591 | -93.28% | |
2023-06-07 | Sale | Conterno Enrique A | Chief Executive Officer | 8,897 0.0093% | $17.04 | $151,583 | -92.99% | |
2023-06-07 | Sale | Chung Christine | SVP, China Operations | 3,633 0.0038% | $17.04 | $61,894 | -92.99% | |
2023-06-07 | Sale | Eisner Mark | EVP, Chief Medical Officer | 2,042 0.0021% | $17.04 | $34,792 | -92.99% | |
2023-06-07 | Sale | Wettig Thane | Chief Commercial Officer | 1,758 0.0018% | $17.04 | $29,951 | -92.99% | |
2023-06-07 | Sale | Schoeneck James A | director | 7,100 0.0079% | $18.03 | $127,987 | -92.99% |
Conterno Enrique A | Chief Executive Officer | 374722 0.381% | $1.06 | 2 | 7 | +14.48% |
Wettig Thane | Chief Commercial Officer | 470178 0.1101% | $1.06 | 2 | 7 | +7.99% |
Adib Deyaa | Chief Medical Officer | 82123 0.0826% | $1.06 | 1 | 0 | |
Henderson Jeffrey William | director | 28866 0.0294% | $1.06 | 0 | 4 | |
RIGGS RORY B | director | 379200 0.3856% | $1.06 | 0 | 7 | |
Cotroneo Pat | SVP, Finance and CFO | 276677 0.2813% | $1.06 | 0 | 51 | |
Chung Christine | SVP, China Operations | 236327 0.2403% | $1.06 | 0 | 29 | |
Yu K Peony | Chief Medical Officer | 192292 0.1955% | $1.06 | 0 | 44 | |
Eisner Mark | EVP, Chief Medical Officer | 162862 0.1656% | $1.06 | 0 | 6 | |
Routti Jorma | director | 131540 0.1338% | $1.06 | 0 | 12 | |
Kouchakji Elias | SVP, Clinical Dev, Drug Safety | 109199 0.111% | $1.06 | 0 | 1 | |
VALONE FRANK H MD | Chief Medical Officer | 104684 0.1065% | $1.06 | 0 | 9 | |
Schoeneck James A | director | 73722 0.075% | $1.06 | 0 | 8 | |
Graham Juan | Chief Financial Officer | 71083 0.0723% | $1.06 | 0 | 6 | |
MADERO MIGUEL | director | 55614 0.0566% | $1.06 | 0 | 2 | |
Tamura Toshinari | director | 51700 0.0526% | $1.06 | 0 | 4 | |
Neff Thomas B | Chief Executive Officer | 44238 0.045% | $1.06 | 0 | 201 | |
KEARNS THOMAS F JR | director | 39764 0.0404% | $1.06 | 0 | 15 | |
EDWARDS JEFFREY L | director | 33977 0.0346% | $1.06 | 0 | 1 | |
Kurkijarvi Kalevi | director | 33100 0.0337% | $1.06 | 0 | 41 | |
Rosenkranz Roberto Pedro | director | 32700 0.0333% | $1.06 | 0 | 15 | |
Ho Maykin | director | 31501 0.032% | $1.06 | 0 | 1 | |
Blaug Suzanne | director | 29594 0.0301% | $1.06 | 0 | 1 | |
Cravatt Benjamin | director | 28736 0.0292% | $1.06 | 0 | 1 | |
Brennan Aoife | director | 27947 0.0284% | $1.06 | 0 | 1 | |
Lema Gerald | director | 3500 0.0036% | $1.06 | 1 | 0 | +19.61% |
PRIMECAP Management Co | $33.89M | 14.5 | 14.42M | -0.35% | -$119,309.50 | 0.03 | |
Armistice Capital Llc | $18.65M | 7.98 | 7.94M | -18.72% | -$4.3M | 0.22 | |
BlackRock | $16.37M | 7.01 | 6.97M | -3.29% | -$557,847.69 | <0.0001 | |
The Vanguard Group | $15.13M | 6.47 | 6.44M | -8.62% | -$1.43M | <0.0001 | |
Acadian Asset Management | $5.88M | 2.52 | 2.5M | +1.42% | +$82,086.84 | 0.02 | |
Jacobs Levy Equity Management | $5.19M | 2.22 | 2.21M | -11.32% | -$662,460.32 | 0.02 | |
State Street | $5.08M | 2.17 | 2.16M | +19.45% | +$827,662.96 | <0.0001 | |
Geode Capital Management | $4.88M | 2.09 | 2.07M | +2.79% | +$132,519.83 | <0.0001 | |
Citadel Advisors LLC | $4.73M | 2.02 | 2.01M | -15.77% | -$885,745.59 | <0.01 | |
683 Capital Management Llc | $4.35M | 1.86 | 1.85M | +164.19% | +$2.7M | 0.49 | |
Two Sigma Advisers LP | $2.83M | 1.21 | 1.2M | -33.11% | -$1.4M | 0.01 | |
Point72 Asset Management | $2.54M | 1.09 | 1.08M | New | +$2.54M | 0.01 | |
Two Sigma | $1.9M | 0.82 | 810,271 | -61.44% | -$3.03M | <0.01 | |
Pennant Capital Management Llc | $1.81M | 0.77 | 768,400 | 0% | +$0 | 0.29 | |
Northern Trust | $1.78M | 0.76 | 756,491 | -2.69% | -$49,237.20 | <0.0001 | |
AQR Capital | $1.3M | 0.55 | 551,280 | -52.69% | -$1.44M | <0.01 | |
Assenagon Asset Management S.A. | $1.01M | 0.43 | 428,848 | -80.74% | -$4.23M | <0.01 | |
Jane Street Capital | $972,581.00 | 0.42 | 413,864 | +9.99% | +$88,329.50 | <0.01 | |
Morgan Stanley | $853,680.00 | 0.37 | 363,268 | -55.51% | -$1.07M | <0.0001 | |
Hudson Bay Capital Management LP | $846,000.00 | 0.36 | 360,000 | New | +$846,000.00 | 0.01 | |
BNY Mellon | $700,342.00 | 0.3 | 298,018 | -4.5% | -$33,033.94 | <0.0001 | |
Fidelity Investments | $693,753.00 | 0.3 | 295,214 | -13.46% | -$107,949.62 | <0.0001 | |
Zurich Cantonal Bank | $691,856.00 | 0.3 | 294,407 | +0.82% | +$5,649.40 | <0.01 | |
Charles Schwab | $627,847.00 | 0.27 | 267,169 | +27.75% | +$136,363.42 | <0.0001 | |
Bridgeway Capital Management | $512,300.00 | 0.22 | 218,000 | New | +$512,300.00 | 0.01 | |
BBR Partners | $508,643.00 | 0.22 | 216,444 | +1,216.25% | +$469,999.63 | 0.04 | |
Bank of America | $509,817.00 | 0.22 | 216,943 | -17.97% | -$111,705.11 | <0.0001 | |
Ameriprise Financial | $482,747.00 | 0.21 | 205,424 | -27.74% | -$185,363.53 | <0.0001 | |
Vantage Consulting Group Inc | $459,911.00 | 0.2 | 195,707 | 0% | +$0 | 0.29 | |
Simplex Trading Llc | $429,000.00 | 0.18 | 182,683 | +643.22% | +$371,278.04 | 0.01 | |
Lighthouse Investment Partners, LLC | $427,916.00 | 0.18 | 182,092 | +18.42% | +$66,570.77 | 0.03 | |
Renaissance Technologies | $391,000.00 | 0.17 | 166,500 | -75.64% | -$1.21M | <0.01 | |
RhumbLine Advisers | $369,501.00 | 0.16 | 157,240 | +1.73% | +$6,290.73 | <0.0001 | |
Walleye Capital | $354,725.00 | 0.15 | 150,947 | New | +$354,725.00 | <0.01 | |
Public Employees Retirement System Of Ohio | $282,437.00 | 0.12 | 120,186 | -31.94% | -$132,556.40 | <0.01 | |
T. Rowe Price | $276,000.00 | 0.12 | 117,258 | +5.25% | +$13,779.05 | <0.0001 | |
Millennium Management LLC | $273,188.00 | 0.12 | 116,250 | -80.86% | -$1.15M | <0.0001 | |
SEI Investments Company | $253,565.00 | 0.11 | 107,900 | 0% | +$0 | <0.0001 | |
Ci Private Wealth Llc | $239,943.00 | 0.1 | 102,103 | 0% | +$0 | <0.0001 | |
UBS | $237,514.00 | 0.1 | 101,070 | +24.66% | +$46,978.75 | <0.0001 | |
Goldman Sachs | $237,747.00 | 0.1 | 101,169 | -55.35% | -$294,673.36 | <0.0001 | |
D. E. Shaw & Co. | $234,941.00 | 0.1 | 99,975 | -94.67% | -$4.17M | <0.0001 | |
JPMorgan Chase | $231,700.00 | 0.1 | 98,596 | +63.97% | +$90,392.52 | <0.0001 | |
Hightower Advisors | $222,000.00 | 0.1 | 94,699 | -60.13% | -$334,799.23 | <0.0001 | |
Voya Investment Management LLC | $218,259.00 | 0.09 | 92,876 | -54.4% | -$260,345.23 | <0.0001 | |
Engineers Gate Manager Lp | $200,124.00 | 0.09 | 85,159 | +0.18% | +$361.90 | 0.01 | |
Nuveen | $195,266.00 | 0.08 | 83,092 | 0% | +$0 | <0.0001 | |
HSBC | $194,366.00 | 0.08 | 82,709 | +1.51% | +$2,885.80 | <0.0001 | |
Group One Trading | $191,344.00 | 0.08 | 81,423 | New | +$191,344.00 | 0.01 | |
AllianceBernstein | $155,688.00 | 0.07 | 66,250 | 0% | +$0 | <0.0001 |